NCT01982214

Brief Summary

A controlled, non-randomized trial will be carried out in 240 postmenopausal women, aged 55-75 years, over a 18-month period. The group 1 received a physical intervention, consisting of whole body vibration (WBV) over 12 months followed by training arrest during 6 months. The group 2 served as sedentary control. WBV training is performed 2 or 3 times per week, with each session lasting 20 minutes. The training included light squats at 35-50 Hz and ended up by stretching and relaxation exercises at 50 Hz. Bone, muscle and postural evaluations will be performed at the beginning, 6, 12 and 18 months in each group with evaluation of bone micro-architectural trabecular and cortical compartments, at the weight bearing tibia and the non weight bearing radius. The primary outcome of the project is the pre, mid, and post evaluations of bone. Bone exploration included dual x-ray absorptiometry (DXA) and high resolution peripheral quantitative computed tomography (HR-pQCT). Bone Mass Density (BMD) will be evaluated by DXA at lumbar, femoral levels and humeral, macro and micro-architectures of the cortical and trabecular compartments will be evaluated in distal radius and tibia by HR-pQCT and bone markers will be analyzed longitudinally. The secondary aim is to assess muscle performance and proprioception. Finally will be assessed markers of cartilage degradation and synthesis, no study has been published on this tissue.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
225

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Apr 2010

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2010

Completed
3.6 years until next milestone

First Submitted

Initial submission to the registry

November 6, 2013

Completed
7 days until next milestone

First Posted

Study publicly available on registry

November 13, 2013

Completed
1.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2015

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2015

Completed
Last Updated

August 10, 2015

Status Verified

August 1, 2015

Enrollment Period

5.3 years

First QC Date

November 6, 2013

Last Update Submit

August 7, 2015

Conditions

Keywords

osteopeniawhole body vibrationwomenbone microarchitecturebone density

Outcome Measures

Primary Outcomes (1)

  • Trabecular bone volume at the femoral neck

    bone densitometric parameters will be evaluated with DXA (dual x-ray absorptiometry)

    12 month

Secondary Outcomes (2)

  • Serum bone markers

    12 month

  • Bone cortical compartment at radius and tibia

    12 month

Study Arms (2)

sedentary

SHAM COMPARATOR

No intervention

Device: sedentary

Vibration

EXPERIMENTAL

Subjects in this group will be submitted to the WBV for 5 to 20 minutes, 2 or 3 times a week while 12 months. The training included light squats at 35-50 Hz and ended up by stretching and relaxation exercises.

Device: Vibration

Interventions

sedentaryDEVICE

No intervention

sedentary
VibrationDEVICE

Subjects will be submitted to the WBV for 5 to 20 minutes, 2 or 3 times a week with frequencies between 35 to 50 Hz while 12 months

Also known as: Power Plate Limited, London, UK
Vibration

Eligibility Criteria

Age55 Years - 75 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Be sedentary (less than 2 hours physical activity of low intensity per week)
  • Fracture risk Densitometry Risk factors (FRAX) index between 3 and 10%
  • Consent form signed

You may not qualify if:

  • Bone concomitant disease (such as Paget's disease, osteomalacia),
  • Endocrinopathy defined on biological criteria (such as Cushing's disease, hyperparathyroidism, hyperthyroidism, hypogonadism),
  • Smoking habits (more than 5 cigarettes per day), chronic alcoholism,
  • Treatments received in the previous 6 months affecting bone metabolism such as anabolics, anti-osteoporotic treatment, corticosteroids.
  • Having a prosthesis (femur and knee),or recently placed metal bouts or plates
  • acute thrombotic problems,
  • severe heart- and vascular diseases,
  • recent injuries due to operation or polyclinical intervention,
  • acute hernia, discopathy, spondylolysis,
  • epilepsy,
  • severe migraine,
  • pacemaker,
  • every neurodegenerative or neuromuscular disease,
  • dementia

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

CHU de Saint-Etienne

Saint-Etienne, 42000, France

Location

MeSH Terms

Conditions

Bone Diseases, Metabolic

Condition Hierarchy (Ancestors)

Bone DiseasesMusculoskeletal DiseasesMetabolic DiseasesNutritional and Metabolic Diseases

Study Officials

  • Thierry THOMAS, MD PhD

    CHU de Saint-Etienne

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 6, 2013

First Posted

November 13, 2013

Study Start

April 1, 2010

Primary Completion

July 1, 2015

Study Completion

July 1, 2015

Last Updated

August 10, 2015

Record last verified: 2015-08

Locations